Clinical Trial Update: A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462 [Phase 1]

View source ↗

Summary

A completed Phase 1 study designed to assess the mass balance recovery, absorption, metabolism, and excretion of [14C]AZD5462 and the absolute bioavailability o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• AZD5462

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure | Phase 1 | Status: COMPLETED